Literature DB >> 29344510

Ablation of FGFR2 in Fibroblasts Ameliorates Kidney Fibrosis after Ischemia/Reperfusion Injury in Mice.

Zhuo Xu1, Chunsun Dai1.   

Abstract

BACKGROUND: Fibroblast growth factors (FGFs) are heparin-binding proteins involved in a variety of biological processes. However, the role and mechanisms of FGF/FGFR2 signaling in fibroblast activation and kidney fibrosis need further investigation.
METHODS: In this study, a mouse model with fibroblast-specific FGFR2 gene disruption was generated. The knockouts were born normal and no kidney dysfunction or histological abnormality was found within 2 months after birth. A kidney ischemia/reperfusion injury (IRI) model was created.
RESULTS: Kidney fibrosis was developed in the control littermates within 2 and 4 weeks after IRI, while in the knockouts, total collagen deposition, fibronectin, and alpha smooth muscle actin expression were decreased compared to those in the control littermates. In addition, the numbers of Ki-67-positive interstitial cells as well as TUNEL-positive interstitial cells were lower in the knockout kidneys at 4 weeks after IRI. Phosphorylated extracellular regulated protein kinase 1/2 was decreased in the knockout kidneys at 2 and 4 weeks after IRI compared to those in the control littermates.
CONCLUSION: These results suggest that FGF/FGFR2 signaling may promote the proliferation and activation of kidney fibroblasts, which contribute to the development of kidney fibrosis.

Entities:  

Keywords:  FGFR2; Fibroblast; Fibrosis; Kidney; Signaling transduction

Year:  2017        PMID: 29344510      PMCID: PMC5757553          DOI: 10.1159/000484604

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  43 in total

1.  Prevalence, detection, evaluation and management of chronic kidney disease.

Authors:  Penny Ackland
Journal:  BMJ       Date:  2014-02-13

Review 2.  Diverse origins of the myofibroblast—implications for kidney fibrosis.

Authors:  Lucas L Falke; Shima Gholizadeh; Roel Goldschmeding; Robbert J Kok; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2015-01-13       Impact factor: 28.314

Review 3.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

4.  Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme.

Authors:  Deepali Pitre Poladia; Kayle Kish; Benjamin Kutay; David Hains; Heather Kegg; Haotian Zhao; Carlton M Bates
Journal:  Dev Biol       Date:  2006-01-24       Impact factor: 3.582

5.  Effect of mammogenic hormones on the expression of FGF7, FGF10 and their receptor in mouse mammary gland.

Authors:  Yingjun Cui; Qingzhang Li
Journal:  Sci China C Life Sci       Date:  2008-08-03

6.  The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.

Authors:  Xuefang Xie; Anamaris M Colberg-Poley; Jharna R Das; Jinliang Li; Aiping Zhang; Pingtao Tang; Marina Jerebtsova; J Silvio Gutkind; Patricio E Ray
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

7.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

8.  Origin and function of myofibroblasts in kidney fibrosis.

Authors:  Valerie S LeBleu; Gangadhar Taduri; Joyce O'Connell; Yingqi Teng; Vesselina G Cooke; Craig Woda; Hikaru Sugimoto; Raghu Kalluri
Journal:  Nat Med       Date:  2013-06-30       Impact factor: 53.440

9.  Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis.

Authors:  Lei Jiang; Lingling Xu; Junhua Mao; Jianzhong Li; Li Fang; Yang Zhou; Wei Liu; Weichun He; Allan Zijian Zhao; Junwei Yang; Chunsun Dai
Journal:  J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 10.121

10.  TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway.

Authors:  Li Xiao; Yan Du; Yang Shen; Ying He; Hui Zhao; Zhenhua Li
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01
View more
  4 in total

Review 1.  Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion.

Authors:  Lian-Cheng Deng; Tahereh Alinejad; Saverio Bellusci; Jin-San Zhang
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

2.  MicroRNA-338-3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression.

Authors:  Cheng Huang; Rui Wang; Jianjun Lu; Yongli He; Yueheng Wu; Wuxia Ma; Jindong Xu; Zejia Wu; Zhe Feng; Min Wu
Journal:  J Clin Lab Anal       Date:  2022-07-06       Impact factor: 3.124

3.  Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.

Authors:  Katarzyna Wolska-Gawron; Joanna Bartosińska; Marta Rusek; Małgorzata Kowal; Dorota Raczkiewicz; Dorota Krasowska
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

Review 4.  MicroRNA Cross-Involvement in Acne Vulgaris and Hidradenitis Suppurativa: A Literature Review.

Authors:  Francesco Borgia; Lucia Peterle; Paolo Custurone; Mario Vaccaro; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.